chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/25/07 Blood and mucous in stool approx 21 days after 2 month old well visit with live Rota vaccines. 2/16/06 right lower quadrant mass palpated but ultrasonic neg intussusception at later visit for another episode. 2/16/07 C difficult toxin positive-pseudomemb. colitis.
feel sick; agitated; I had red  swollen spots eczema on my arms then lower legs after two days; I also  am having more fatigue with physical effort -after very simple tasks such as climbing stairs; This is a spontaneous report from a contactable consumer (Patient herself). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 07Jun2021 at 16:30 (at the age of 51-year-old) as single dose for covid-19 immunisation at Pharmacy or Drug Store. Patient was not pregnant at the time of vaccination. Medical history included depression, anxiety and sleep issues from an unknown date and unknown if ongoing. The patient was not diagnosed with COVID-19 before vaccination. Patient had no known allergies but very sensitive to any medications. Concomitant medication(s) included zinc (ZINC); vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]); ubidecarenone (Q10); st john's wort (ST JOHN'S WORT) and panax ginseng (GINSENG [PANAX GINSENG]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received zinc, vitamin D, Q10, saint John's wort and Ginseng within 2 weeks of vaccination. Patent reported I started to feel sick and agitated, not being able to do anything after 3 days of having the second dose not really being aware from what it is from. I had it on Monday at 4 pm and on Sunday I was at the urgent care in another state where I was travelling because starting on Saturday, I had red swollen spots of eczema on my arms then lower legs after two days I called again to my virtual doctor and had a virtual visit. had a pack of methylprednisolone and after it I tried prednisone few days and went back for another few days on methylprednisolone ll this time I took Claritin orally at the end I started using Hydrocortisone cream and zinc cream and hypnosis those last worked so I improved after 2 weeks minimum I want refund for all my urgent care visit and copy for my virtual visit and all over the counter creams I had to purchased I also I am having more fatigue with physical effort after very simple tasks such as climbing stairs I plan to see a cardiologist. Since vaccination patient not tested for covid-19. This case assessed as non-serious by the reporter. Events resulted to visit Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events with methylprednisolone, prednisone, Claritin orally, Hydrocortisone cream and zinc cream and hypnosis. The outcome of the events was reported as recovering.  Information on the Batch/lot number has been requested.
Pt was given PENTACEL dose #4 one week after dose #3 was given. Mom denies any SX.
Rash around the neck area that spread to chest and back of the neck later in the day. Very itchy and have a burning sensation.  The lymph node in the left neck area where the rash is, feels swollen.
High fever (103), severe headache, chills, sweats, some nausea. Treated with Tylenol every 4 hours, fluids, ice packs, rest
pt recv vax & w/in 24 hr pt did not feel well for a few days;event resolved;
JOINT PAIN; FEVER; EXHAUSTION; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included none. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced joint pain. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from joint pain, fever, and exhaustion. This report was non-serious.
adjuvant was not reconstituted with powder; patient received only  adjuvant; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) (batch number A45FG, expiry date 23rd April 2023) for prophylaxis.   On 8th July 2022, the patient received Shingrix. On 8th July 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 13-Jul-2022 Reporter's Comments: The nurse reported a patient received only the Shingrix adjuvant (without reconstitution with powder on 8th July 2022 The reporter consented to follow up. Additional Supportive Information:  The patient only received shingrix adjuvant without reconstitution with powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is 1 of 2 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022106154:Same reporter. Patient 1
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Lot number: EN6205), in left arm, on 25Mar2021 as dose 2, single (Lot number: EN6204), in right arm and on 30Sep2021 as dose 3 (booster), single (Lot number: FC3180) at the age of 55 years, in right arm for covid-19 immunization; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 16Apr2022 as dose 4 (booster), single (Lot number: 002M21A), in right arm for covid-19 immunization. The patient's relevant medical history included: "Type II diabetes" (unspecified if ongoing), notes: Type II diabetes; "high blood pressure" (unspecified if ongoing), notes: high blood pressure; "depression" (unspecified if ongoing) and " chronic congestion". Concomitant medication(s) included: METFORMIN; MONTELUKAST; LOSARTAN; SERTRALINE; LORATADINE; VITAFUSION FIBER WELL FIT, Kirkland mature multivitamin, also reported as patient received other medications in two weeks of starting COVID-19 treatment. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20May2022) Negative, notes: Positive test result 6 days after negative result; (26May2022) Positive, notes: Positive test result 6 days after negative result. Therapeutic measures were taken as a result of covid-19, vaccination failure included Paxlovid started on 15May2022 and stopped on 20May2022. Clinical course was reported as, Positive test result 6 days after negative result and end of Paxlovid treatment. Symptoms (very mild so far) have resumed as well on 26May2022. No treatment received for symptoms and patient was not recovered from symptoms.  No follow-up attempts are possible. No further information is expected.
This case was reported by a healthcare professional (distributor) and described the occurrence of injection site tenderness in a subject of unspecified age and gender who was vaccinated with Flulaval (GlaxoSmithKline) for prophylaxis.  On an unspecified date the subject received unspecified dose of Flulaval (unknown).  At an unspecified time after vaccination with Flulaval, the subject experienced injection site tenderness.  At the time of reporting the outcome of the event was unspecified.
15 hours after vaccinated started feeling ill, headache, nausea, vomiting. To hospital where diagnosed w/ meningitis. Died a few days later.
Patient has history of seizure disorder but had not had seizures since Spring of 2008.  Gardasil recv'd at 3pm on 11/5 and between midnight and 4am of 11/6 had 5-6 seizures.
Strong frequent (about every 10-15 seconds) PVCs began 3-4 hours after second injection. They lasted for more than 3 days and broke through beta blocker even when taking a slightly higher dose. After three months am experiencing less PVCs but low heart rate. Working with congenital cardiologist to find resolution.
Nine days after receiving the Measles vaccine (single dose, not MMR), my son developed a slight fever (about 101F) which rose to 102.7F within 24 hours. During this time we administered children's Tylenol, as well as warm baths.
My arm has progressively worsened with pain.  It ached at first (as normal), but now going on 3 weeks I am in significant pain that seems to be getting worse not better.  Pulling a shirt over my head is extremely difficult. Raising my arm over my head hurts.  My arm is more sore and has been sore far longer than my Hepatitis B shots!
This spontaneous report was received from a 50 year old pharmacist regarding herself, the patient has no pertinent medical history or drug allergies. On 03-OCT-2013, while preparing ZOSTAVAX (lot# J005848, expiry date 17-AUG-2014) injection, the pharmacist pressed on the syringe plunger in error and some ZOSTAVAX sprayed into her eyes. She rinsed her eyes with water. The patient experienced discomfort in her eyes. Concomitant medications were none. The outcome of discomfort in her eyes was reported as not recovered. There was no lab tests performed. The patient did not seek medical attention. Additional information has been requested.
Information has been received from a consumer concerning her 32 year old daughter who recently received a booster dose for MMR II. It was reported that she developed mumps and ended up being admitted to the hospital. No product quality complaint involved. This is one of several reports from the same source. Additional information has been requested.
Day 8 post injection - redness and itching below and to the side of  injection site . Improved with topical hydrocortisone
Right submandibular lymph node swelling, facial/ear pain (ongoing but getting better-antibiotics given)  Right facial numbness/droop diagnosed as Bell?s Palsy right side (ongoing)
1st Injection:  Localized "Moderna Arm"; left arm injection site slightly itchy;  resolved in 1-2 weeks.  2nd Injection: Diffuse "Moderna Arm"; right arm injection site significantly itchy; swollen; general malaise 2 weeks.  4-6 weeks following 2nd injection, I began experiencing a spontaneous, severe pain in the areolar/nipple area of right breast, which would gradually fade.  At first I thought it was due to rubbing the bra, so I went without a bra for a week, but it continued to occur, sometimes several times over a several hour span.  This continued for several weeks, before it faded to just a mild discomfort.  It was still in the discomfort stage when I mentioned it to my physician at my regularly scheduled visit on June 24, 2021.   I did not note any tenderness or swollen lymph nodes in the right axilla area or elsewhere in the right breast.  I do recall the pain in the nipple area being sharp and gradually subsiding over a period of minutes, until it would strike again.
Initial case was received from a health care professional on 09 October 2013. An patient (Age and gender unknown) had medical history of allergies to latex reported, received a dose reported and Batch number 25355 which is not a Sanofi batch number). Patient had not reported concomitant medication. It was reported that on an unspecified date patient had swelling of hands and feet and hives. No corrective treatment was reported. At the time of report the outcome of event was unknown.
Had an allergic reaction to the shot. Right palm started itching. Tingling in the facial area. Lips went numb for a short period. No breathing issue. Event lasted about 3.5 hrs. after the shot .No treatment.
9AUG91 DTP/OPV given; 10AUG early AM t103 reduced temp w/APAP given q 4 hrs; 11AUG91 temp & vomiting; Seen by MD 11AUG91 ER w/serious vomiting; 12AUG91 vomiting, temp, diarrhea; MD felt due to DTP inject;
Left ankle swelled up; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Left ankle swelled up) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     The patient's past medical history included Ankle fracture (Broken both ankles.).    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced JOINT SWELLING (Left ankle swelled up). On 22-Apr-2021, JOINT SWELLING (Left ankle swelled up) had resolved.            No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-273111 (Patient Link).
immediately after administering the fluzone flu vaccine IM left arm, patient's upper arm (deltoid) began to swell to about the size of a golf ball.  red and purple in color .  the swelling was instant and did not worsen after a few minutes
Cas number PHEH2013US012015, is an initial spontaneous report received from a pharmacist on 31 May 2013: This case refers to a 19-year-old female patient. She received only Men C, Y, W-135 liquid conjugate component of MENVEO, (batch number: A12011), intramuscularly without being reconstituted with Men A component on 31 May 2013. No adverse reaction reported following this administration error.
Pt recvd vax 9JAN91 & 3 wks p/vax dx as having rotator cuff inflammation in the opposite arm to that in which inject was given; pt was treated w/Ibuprofen;
I developed an itchy raised rash all over my body.  First night seemed minor.  Woke up next day and my ears where both swollen and covered with rash and there was more noticeable areas on arms and wrists.  Took some zyrtec and applied benadryl to control itching.  By 5 pm small rash spots had spread together and gotten more raised and were now noticed everywhere, such as arm pits, fore arms, hands, breasts, trunk, legs, ears and face.  Called Teledoc and was prescribed Medrol Dosepak 4 mg.  I was able to take 3 the first night but it was still bad when went to sleep.  Had improved by next morning.  Rash still visible is worst areas but was no longer raised. Treatment seems to be working gets better each day.  Only slight rash discoloration visible is worst areas.
rash; her sister went out to dinner with her in-laws like through marriage on Saturday night and the husband has this too Skin lesion; her sister went out to dinner with her in-laws like through marriage on Saturday night and the husband has this too, terrible itching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "rash "; SKIN LESION (non-serious), outcome "unknown", described as "her sister went out to dinner with her in-laws like through marriage on Saturday night and the husband has this too Skin lesion"; PRURITUS (non-serious), outcome "unknown", described as "her sister went out to dinner with her in-laws like through marriage on Saturday night and the husband has this too, terrible itching".  Additional Information: The patient did not taken any other vaccine prior vaccinations or within 4 weeks and no medical history. He was not in emergency room. The man at the gym said he had the vaccine and he went to the doctor and beginning of vaccination there was nothing there and everybody looks at you like you are a mental case and said yeah but are you still itchy and goes.  The lot number for bnt162b2 was not provided and will be requested during follow up.
The next morning after the vaccination pt had a sore arm and felt achy with chills but remained at work. No problems until 4 days later. Pt hands felt sl. swollen and like they were on fire. After that she noticed 2 blister-like welts about the size of a silver dollar on the top of her legs. They faded away after a short time. For the next 3 days (about once a day) pt. would feel like her hands were on fire and then she would notice a group of "welts" ranging in size from 6 mm to 1-2 mm that would appear on her arms, legs, buttocks either on top or on inner aspect of the limb. They would fade away after short time. She did not see a physician but took oral BENADRYL and spray BENADRYL for the welts. It seemed to help. They didn't hurt or itch but seemed to appear after a hot shower and once after working outside in 90 degree weather. After Sept 3, 2018 the pt. had no further problems.
Patient woke up at 3 am sweating, with severe headache like someone hit him in the back of the head. He has pain and rash around the shot area. He also has sinus congestion and could not breath via nose. Symptoms last for 3 days.
Patient presented to the pharmacy with left arm swelling, redness, and warmth at injection site that was given over 1 week ago. Patient's arm has been hurting since getting the vaccine and experiencing these symptoms. I advised her to call her doctor. Shortly thereafter, a prescription was phoned in for Cipro and Medrol Dose Pak
blisters / on the stomach and on both arms and feet; blisters looked like chicken pox.; rash / on the back of the neck / extended to the head / abdomen and waist; rash was red; itching/The rash was red, and itching.; This case was reported by a pharmacist via call center representative and described the occurrence of chickenpox in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number 47D2Z, expiry date 24th April 2022) for prophylaxis.   On 27th July 2020, the patient received the 1st dose of Shingrix (intramuscular). In July 2020, 2 days after receiving Shingrix, the patient experienced chickenpox, rash, red rash and itchy rash. In August 2020, the patient experienced blister. The patient was treated with triamcinolone (Triamcinolone Cream). On an unknown date, the outcome of the chickenpox, rash, red rash, itchy rash and blister were unknown.   It was unknown if the reporter considered the chickenpox, rash, red rash, itchy rash and blister to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid intramuscularly and 2 days later a rash developed on the back of the neck which extended to the head.  There was also rash on the left side of the abdomen and waist.  The rash was red, and itching.  Two weeks later blisters were noted on the stomach and on both arms and feet.  The pharmacist stating the blisters looked like chicken pox.  The patient was seen by a doctor and was prescribed triamcinolone cream but the patient was still itching.  The pharmacist was stating the adverse events had not resolved but had actually gotten worse. The reporter did not consent to follow up.
Erythematous, pruritic papular rash on head, arms, face starting on day #10 post vaccination
Pain at injection site; Severe stomach discomfort; Nausea; Extreme Fatigue; Stomach pains; gas; This is a spontaneous report from a contactable consumer or other non hcp reporting for himself (patient). A 51-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EP7534, expiry date: unknown) via an unspecified route of administration, administered in Arm Left on 21Mar2021 at 15:15 (at the age of 51-year-old) as dose 1, single for covid-19 immunization at other facility. Medical history included High blood pressure and DVT. Patient was allergic to Floxin. Concomitant medication(s) included nebivolol hydrochloride (BYSTOLIC), rivaroxaban (XARELTO) and azilsartan kamedoxomil (EDARBI). The patient had not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. The patient received no other vaccines within 4 weeks prior to the COVID vaccine. On 21Mar2021 at 05:45PM, patient experienced Stomach pains/gas. On 21Mar2021 03:30 PM the patient experienced pain at injection site, severe stomach discomfort, nausea and extreme fatigue. No treatment was received in response to the events. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Headache, fatigue, swollen lymph nodes, generally feeling sick, neck and shoulder pain
This spontaneous report as received from a nurse refers to a 6 months 9 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse experiences have been reported so fr. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Chills; FEVER 99.8; Foggy Brain; Fatigue after 12 hours-slept 20 hours (extreme); This is a spontaneous report from a contactable consumer or other non hcp. A 48-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL2302), via an unspecified route of administration, administered in Arm Left on 23Jan2021 12:30 as single dose for covid-19 immunization. The patient medical history was not reported. The patient concomitant medication included Levothyroxine (LEVOTHYROXINE) (MANUFACTURER UNKNOWN) taken for an unspecified indication from 2000 and ongoing; Dulera (FORMOTEROL FUMARATE, MOMETASONE FUROATE) (MANUFACTURER UNKNOWN) taken for an unspecified indication from 2018 and ongoing; salbutamol (ALBUTEROL HFA) (MANUFACTURER UNKNOWN)  taken for an unspecified indication from 2017 and ongoing; omeprazole (PROTONIX [OMEPRAZOLE]) taken for an unspecified indication from 2016 and ongoing; alprazolam (XANAX) (MANUFACTURER UNKNOWN)  (Do not take day before or week after) taken for an unspecified indication from 2000 and ongoing. On 23Jan2021, patient experienced severe fatigue after 12 hours slept (total fatigue was 5 days (with initial being worst)). Patient experienced Chills, foggy brain (4 days) on an unspecified date. Patient experienced fever 99.8 after each dose, side effects were twice as bad after 2nd dose, but didn't start until after 12 hours. No admission to hospital due to the event, No Any treatment received. The outcome of the event Fatigue after 12 hours slept, Chills was recovered. The outcome of the events Chills and Foggy Brain were unknow.
Patient called 08/18/2015 stating her arm hurts to the point where she is unable to really move it and starting to look red at injection site.  Instructed patient to be seen by doctor.